Detalhe da pesquisa
1.
Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens.
J Antimicrob Chemother
; 78(11): 2696-2701, 2023 11 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37725999
2.
Who is lost to follow-up in HIV care? Assessment of care retention over time and the impact of COVID-19. Longitudinal analysis of the PISCIS cohort.
HIV Med
; 24(9): 965-978, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36990962
3.
Comparison of Hospitalized Coronavirus Disease 2019 and Influenza Patients Requiring Supplemental Oxygen in a Cohort Study: Clinical Impact and Resource Consumption.
Clin Infect Dis
; 75(12): 2225-2238, 2022 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35442442
4.
Bone density, microarchitecture and tissue quality after 1 year of treatment with dolutegravir/abacavir/lamivudine.
J Antimicrob Chemother
; 75(10): 2998-3003, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32710105
5.
Factors associated with the number of drugs in darunavir/cobicistat regimens.
J Antimicrob Chemother
; 75(1): 208-214, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31586414
6.
Dual Therapy With Darunavir and Ritonavir Plus Lamivudine vs Triple Therapy With Darunavir and Ritonavir Plus Tenofovir Disoproxil Fumarate and Emtricitabine or Abacavir and Lamivudine for Maintenance of Human Immunodeficiency Virus Type 1 Viral Suppression: Randomized, Open-Label, Noninferiority DUAL-GESIDA 8014-RIS-EST45 Trial.
Clin Infect Dis
; 65(12): 2112-2118, 2017 Nov 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-29020293
7.
PD-L1 Blockade Differentially Impacts Regulatory T Cells from HIV-Infected Individuals Depending on Plasma Viremia.
PLoS Pathog
; 11(12): e1005270, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26633181
8.
Costs and cost-efficacy analysis of the 2016 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.
Enferm Infecc Microbiol Clin
; 35(2): 88-99, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27459919
9.
Effectiveness and safety of an abacavir/lamivudineâ+ârilpivirine regimen for the treatment of HIV-1 infection in naive patients.
J Antimicrob Chemother
; 71(12): 3510-3514, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27591292
10.
[Economic impact of nosocomial bacteraemia. A comparison of three calculation methods]. / Impacto económico de las bacteriemias nosocomiales. Comparación de tres metodologías de cálculo.
Enferm Infecc Microbiol Clin
; 34(10): 620-625, 2016 Dec.
Artigo
em Espanhol
| MEDLINE | ID: mdl-26564375
11.
Costs and cost-effectiveness analysis of 2015 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.
Enferm Infecc Microbiol Clin
; 34(6): 361-71, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26321131
12.
Executive summary: Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.
Enferm Infecc Microbiol Clin
; 34(8): 517-23, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27056581
13.
Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.
Enferm Infecc Microbiol Clin
; 34(8): 516.e1-516.e18, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26976381
14.
Virological failure to raltegravir in Spain: incidence, prevalence and clinical consequences.
J Antimicrob Chemother
; 70(11): 3087-95, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26490727
15.
Drug-drug interactions of telaprevir and boceprevir in HCV-monoinfected and HIV/HCV-coinfected patients can modify the adherence.
Liver Int
; 35(5): 1557-65, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25385188
16.
Epidemiology of infections by HIV, Syphilis, Gonorrhea and Lymphogranuloma Venereum in Barcelona City: a population-based incidence study.
BMC Public Health
; 15: 1015, 2015 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26438040
17.
Costs and cost-efficacy analysis of the 2014 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.
Enferm Infecc Microbiol Clin
; 33(3): 156-65, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25175171
18.
[Barriers to ART initiation in HIV infected subjects and with treatment indication in Spain. Why don't they start their treatment? Bridgap Study]. / Barreras para el inicio del tratamiento antirretroviral en pacientes con virus de la inmunodeficiencia humana e indicación de tratamiento en España. ¿Por qué no inician tratamiento quienes lo tienen indicado? Estudio Bridgap.
Enferm Infecc Microbiol Clin
; 33(6): 397-403, 2015.
Artigo
em Espanhol
| MEDLINE | ID: mdl-25577557
19.
Executive summary of the GESIDA/National AIDS Plan Consensus Document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2015).
Enferm Infecc Microbiol Clin
; 33(8): 544-56, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26021186
20.
Effectiveness of ritonavir-boosted protease inhibitor monotherapy in the clinical setting: same results as in clinical trials? The PIMOCS Study Group.
J Antimicrob Chemother
; 69(5): 1390-6, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24415645